Loading...
Panobinostat sensitizes cyclin E high, homologous recombination-proficient ovarian cancer to olaparib
OBJECTIVE: Homologous recombination (HR) proficient ovarian cancers, including CCNE1 (cyclin E)-amplified tumors, are resistant to poly (ADP-ribose) polymerase inhibitors (PARPi). Histone deacetylase inhibitors (HDACi) are effective in overcoming tumor resistance to DNA damaging drugs. Our goal was...
Na minha lista:
| Udgivet i: | Gynecol Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5031537/ https://ncbi.nlm.nih.gov/pubmed/27444036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2016.07.088 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|